ReShape Lifesciences
Stock Forecast, Prediction & Price Target
ReShape Lifesciences Financial Estimates
ReShape Lifesciences Revenue Estimates
ReShape Lifesciences EBITDA Estimates
ReShape Lifesciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $13.6M N/A | $11.24M -17.35% | $8.67M -22.79% | Avg: $11.99M Low: $11.99M High: $11.99M avg. 38.20% | |||
Net Income
% change YoY
| $-61.93M N/A | $-46.21M 25.38% | $-11.38M 75.36% | Avg: $-5.76M Low: $-2.14M High: $-2.14M avg. 49.39% | |||
EBITDA
% change YoY
| $-27.74M N/A | $-24.91M 10.21% | $-14.48M 41.85% | Avg: $-11.99M Low: $-11.99M High: $-11.99M avg. 17.20% | |||
EPS
% change YoY
| -$283.42 N/A | -$108.9 61.57% | -$110.88 -1.81% | Avg: -$0.36 Low: -$0.36 High: -$0.36 avg. 99.67% | |||
Operating Expenses
% change YoY
| $36.09M N/A | $33.88M -6.14% | $20.18M -40.41% | Avg: $24.28M Low: $24.28M High: $24.28M avg. 20.32% | |||
FAQ
What is ReShape Lifesciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 49.39% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -2.14M, average is -5.76M and high is -2.14M.
What is ReShape Lifesciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 38.20% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $11.99M, average is $11.99M and high is $11.99M.
What is ReShape Lifesciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 99.67% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.36, average is -$0.36 and high is $-0.36.